2016 FDA labeling discourage quinolones (tendinopathy, interstitial nephitis) use. Since QUIN Rx have steadily dropped for UTI, sinusitis & COPD with shift to nitrofurantoin, amoxil, macrolides & tetracyclines. Still QUIN used in 15-19% of UTIs and COPD https://t.co/Yq2c8YFUog